Failed 2023

    Mfine Singapore (Wind-Down)

    Singapore-headquartered telehealth Mfine raised US$60M during COVID then heavily downsized as Asian telehealth demand normalized.

    TL;DR — Failure Post-Mortem

    Mfine Singapore (Wind-Down) was a Healthtech startup founded in 2017 in Singapore. It raised $60M before collapsing in 2023 — 6 years of runway burned. IdeaProof's AI Failure Score: 0/100, driven by post-covid demand collapse. The shutdown affected employees, investors, and the broader Healthtech ecosystem. This case study breaks down the timeline, root causes, competitors that won, and replicable lessons for founders validating similar ideas today.

    Why did Mfine Singapore (Wind-Down) fail?

    Mfine Singapore (Wind-Down) failed in 2023 after 6 years of operation, losing $60M in raised capital. The root cause was post-covid demand collapse. Key lesson: Singapore-headquartered telehealth Mfine raised US$60M during COVID then heavily downsized as Asian telehealth demand normalized.

    Verifiable facts
    Sourced
    Founded → Closed

    2017 → 2023

    Funding Raised

    $60M

    Industry

    Healthtech

    Country

    Singapore

    Causal Chain

    Derived · heuristic

    This is our reading of the causal chain — separated from the verifiable facts above. Timeline dates, funding numbers and filings are facts (see methodology); root / proximate / terminal attribution is judgement based on public evidence.

    Root cause

    A combination of demand-side, execution, and capital-market pressures that this record documents without isolating a single dominant driver.

    Contributing factors
    • Sector context: Healthtech in Singapore, 6 years of runway.
    Terminal event

    2023: cessation of operations after failing to secure additional capital or a strategic buyer.

    Base rates

    External sources

    A single failure is an anecdote. These base rates give you the denominator — how common this outcome is across all startups matching Mfine Singapore (Wind-Down)'s profile. Sources are third-party; we do not restate them as our own claims.

    ~70%
    industry

    of digital-health startups fail to reach breakeven; reimbursement complexity + regulatory approvals extend runway needs beyond typical VC horizons.

    Rock Health State of Digital Health (2023)
    ~90%
    all

    of startups ultimately fail — including ~10% that fail in the first year and the rest across the following decade.

    Startup Genome / CB Insights aggregate (2024)
    ~35%
    all

    of new US employer businesses survive past their 10th year (Bureau of Labor Statistics BED series).

    US Bureau of Labor Statistics — BED (2024)
    ~35%
    stage

    of Series A rounds ever graduate to Series B; the rest run out of runway or pivot without a follow-on.

    CB Insights Venture Capital Funnel (2023)

    Full Analysis

    Singapore-headquartered (India-operating) telehealth Mfine raised over US$60M during COVID. As Asian telehealth demand normalized, the company laid off most staff in 2022-23 and was reportedly acquired by LifeWell Health Pvt Ltd in a soft outcome. A useful regional telehealth post-mortem.

    Could This Failure Have Been Prevented?

    IdeaProof's AI validates market demand, competitive positioning, and business model viability in minutes — catching the exact issues that sank Mfine Singapore (Wind-Down).

    Related Failures

    Tehama (Wind-Down)

    $30M · 2023

    Post-COVID Demand Collapse

    Spotted a factual error?

    Approved corrections are published in the public changelog with attribution.